Rigel Pharma (RIGL) Reports In-Line Q4 EPS, Revenues Beat
Go back to Rigel Pharma (RIGL) Reports In-Line Q4 EPS, Revenues Beat| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 42.45 -0.13 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.58 | 52 Week High | $4.38 | |||
| Open | $42.90 | 52 Week Low | $1.88 | |||
| Day High | $43.26 | P/E | N/A | |||
| Day Low | $42.08 | EPS | $-1.12 | |||
| Volume | 429,214 | |||||
